Autosomal Dominant Polycystic Kidney Disease (ADPKD) Study | MicrobiomeTrials← Back to trialsNCT04338048
Autosomal Dominant Polycystic Kidney Disease (ADPKD) Study
RecruitingOBSERVATIONAL
Trial Details
Start: 2019-10-10Est. Completion: 2030-10-30
Enrollment target: 300 participants Locations- Children's National Hospital, Washington D.C., District of Columbia, United States
- Mayo Clinic, Rochester, Minnesota, United States
- Cohen Children's Medical Center, New Hyde Park, New York, United States
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Other microbiome trials you might be interested in
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
The purpose of this study is to estimate the prevalence, demographic, and clinical characteristics of PKD1/2 gene varian…
Alabaster, United StatesEst. completion Dec 31, 2026
Autosomal Dominant Polycystic Kidney
This study will evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of GBP-2…
Shanghai, ChinaEst. completion Jul 2027
Recruiting
In this study, the researchers want to learn more about the safety and effectiveness of Molidustat in Japanese men and w…
Multiple Locations, JapanEst. completion Jun 30, 2027